Home > Products > Biosimilars

BioSIM anti-Human IL-13 Antibody (Tralokinumab Biosimilar), Research Grade

Catalog: SIM0669
Clone: SIM0042
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar, with the same variable regions as therapeutic Tralokinumab (a fully humanized IgG4 mAb), is ideal for research. Tralokinumab binds IL-13 (an inflammatory cytokine linked to allergic inflammation, atopic dermatitis, activating JAK/STAT pathways). It blocks IL-13-receptor interactions, neutralizes IL-13 in vitro, and inhibits airway hyperresponsiveness/eosinophilia in humanized mice/cynomolgus monkeys in vivo.
 

Specifications

Product Name BioSIM anti-Human IL-13 Antibody (Tralokinumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype /
Target IL-13
Other Names CAT-354, CAS: 1044515-88-9
CAS 1044515-88-9
Reactivity Human
Host Species Human
Background This non-therapeutic biosimilar, with the same variable regions as therapeutic Tralokinumab (a fully humanized IgG4 mAb), is ideal for research. Tralokinumab binds IL-13 (an inflammatory cytokine linked to allergic inflammation, atopic dermatitis, activating JAK/STAT pathways). It blocks IL-13-receptor interactions, neutralizes IL-13 in vitro, and inhibits airway hyperresponsiveness/eosinophilia in humanized mice/cynomolgus monkeys in vivo.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products